rs430554

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_173354.5(SIK1):​c.1844C>T​(p.Ala615Val) variant causes a missense change. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A615T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.057 ( 498 hom., cov: 0)
Exomes 𝑓: 0.065 ( 9830 hom. )
Failed GnomAD Quality Control

Consequence

SIK1
NM_173354.5 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 5.79

Publications

25 publications found
Variant links:
Genes affected
SIK1 (HGNC:11142): (salt inducible kinase 1) This gene encodes a serine/threonine protein kinase that contains a ubiquitin-associated (UBA) domain. The encoded protein is a member of the adenosine monophosphate-activated kinase (AMPK) subfamily of kinases that play a role in conserved signal transduction pathways. A mutation in this gene is associated with early infantile epileptic encephalopathy 30. [provided by RefSeq, Nov 2016]
SIK1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 30
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • early myoclonic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • generalized epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.6161289E-6).
BP6
Variant 21-43417675-G-A is Benign according to our data. Variant chr21-43417675-G-A is described in ClinVar as Benign. ClinVar VariationId is 586585.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SIK1NM_173354.5 linkc.1844C>T p.Ala615Val missense_variant Exon 13 of 14 ENST00000270162.8 NP_775490.2
SIK1XM_011529474.3 linkc.1697C>T p.Ala566Val missense_variant Exon 12 of 13 XP_011527776.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SIK1ENST00000270162.8 linkc.1844C>T p.Ala615Val missense_variant Exon 13 of 14 1 NM_173354.5 ENSP00000270162.6

Frequencies

GnomAD3 genomes
AF:
0.0572
AC:
2139
AN:
37422
Hom.:
495
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0558
Gnomad AMI
AF:
0.00806
Gnomad AMR
AF:
0.0392
Gnomad ASJ
AF:
0.0626
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0351
Gnomad FIN
AF:
0.0702
Gnomad MID
AF:
0.159
Gnomad NFE
AF:
0.0663
Gnomad OTH
AF:
0.0527
GnomAD2 exomes
AF:
0.888
AC:
192033
AN:
216326
AF XY:
0.887
show subpopulations
Gnomad AFR exome
AF:
0.736
Gnomad AMR exome
AF:
0.941
Gnomad ASJ exome
AF:
0.841
Gnomad EAS exome
AF:
0.900
Gnomad FIN exome
AF:
0.961
Gnomad NFE exome
AF:
0.889
Gnomad OTH exome
AF:
0.875
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0649
AC:
21219
AN:
327096
Hom.:
9830
Cov.:
0
AF XY:
0.0680
AC XY:
10998
AN XY:
161722
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0721
AC:
1008
AN:
13974
American (AMR)
AF:
0.0921
AC:
376
AN:
4082
Ashkenazi Jewish (ASJ)
AF:
0.136
AC:
926
AN:
6784
East Asian (EAS)
AF:
0.000921
AC:
7
AN:
7598
South Asian (SAS)
AF:
0.0543
AC:
1102
AN:
20286
European-Finnish (FIN)
AF:
0.267
AC:
1268
AN:
4756
Middle Eastern (MID)
AF:
0.0989
AC:
130
AN:
1314
European-Non Finnish (NFE)
AF:
0.0588
AC:
14878
AN:
253046
Other (OTH)
AF:
0.0999
AC:
1524
AN:
15256
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.270
Heterozygous variant carriers
0
175
349
524
698
873
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0573
AC:
2147
AN:
37466
Hom.:
498
Cov.:
0
AF XY:
0.0563
AC XY:
984
AN XY:
17480
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0560
AC:
897
AN:
16012
American (AMR)
AF:
0.0392
AC:
93
AN:
2372
Ashkenazi Jewish (ASJ)
AF:
0.0626
AC:
62
AN:
990
East Asian (EAS)
AF:
0.00
AC:
0
AN:
878
South Asian (SAS)
AF:
0.0352
AC:
42
AN:
1194
European-Finnish (FIN)
AF:
0.0702
AC:
56
AN:
798
Middle Eastern (MID)
AF:
0.159
AC:
13
AN:
82
European-Non Finnish (NFE)
AF:
0.0663
AC:
953
AN:
14376
Other (OTH)
AF:
0.0562
AC:
29
AN:
516
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.273
Heterozygous variant carriers
0
118
236
354
472
590
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.855
Hom.:
75693
TwinsUK
AF:
0.875
AC:
3243
ALSPAC
AF:
0.873
AC:
3365
ESP6500AA
AF:
0.757
AC:
3275
ESP6500EA
AF:
0.890
AC:
7596
ExAC
AF:
0.866
AC:
102141
Asia WGS
AF:
0.849
AC:
2955
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 30 Benign:3
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 31, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 100% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 93. Only high quality variants are reported. -

Inborn genetic diseases Benign:1
Dec 31, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.089
T
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.48
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.51
T
MetaRNN
Benign
0.0000016
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.0
L
PhyloP100
5.8
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.90
N
REVEL
Benign
0.20
Sift
Uncertain
0.0050
D
Sift4G
Benign
0.28
T
Polyphen
0.28
B
Vest4
0.039
MPC
0.16
ClinPred
0.032
T
GERP RS
2.3
Varity_R
0.088
gMVP
0.12
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs430554; hg19: chr21-44837555; COSMIC: COSV54258894; COSMIC: COSV54258894; API